Emergency Filtration Products' Nogales, Mexico Facility Commences NanoMask Filter Production
Combined with the company's Henderson, Nev., production facility, the company expects to be able to produce approximately 1 million NanoMask filters per week, enabling it to fulfill its supply commitments to its international and domestic distributors, as well as pursue large retail and medical products customers with whom EFP has already held discussions. Importantly, the company has designed its Nogales facility to accommodate substantial increases in production from the current projected levels of 750,000 filters per week as demand dictates.
“Now that Mexico is in production, we are finally able to pursue business with a number of large potential customers with whom we have been in contact”
"Now that Mexico is in production, we are finally able to pursue business with a number of large potential customers with whom we have been in contact," said Douglas K. Beplate, president and CEO, EFP. "We will now concentrate our efforts on obtaining large-scale orders for our products, something that we were unable to do because of supply constraints. Demand for our NanoMask and NanoMask filters continues to be strong."
About the NanoMask
EFP's 2H Nano-Enhanced Environmental Mask, the NanoMask, relies on the company's core 2H Technology(TM) filtration system, which utilizes a combination of hydrophobic and hydrophilic filters able to capture and isolate bacterial and viral microorganisms with efficiencies of 99.9%. The environmental mask utilizes the company's patented 2H Technology(TM) and nanotechnology to enhance the capture-and-isolation characteristics of the filter media. For an independent discussion of the NanoMask excerpted from the book "H5N1Virus: How to Protect Your Family Against the Coming Pandemic," visit http://emergencyfiltration.com/H5N1 Excerpt.htm.
About Emergency Filtration Products
EFP is an air filtration products manufacturer whose patented 2H Technology(TM) filter system has produced filtration efficiencies of "greater than 99.99%" at a particulate size of 0.027 microns. Its initial products were developed for the medical market: the Vapor Isolation Valve(TM) and RespAide(R) CPR Isolation Mask used for resuscitation of respiratory/cardiac arrest cases; and the 2H Breathing Circuit Filter for ventilators, respirators and anesthesia circuitry. Each has received FDA approval. The company also markets an Automated External Defibrillator Prep Kit featuring RespAide; and the NanoMask(R), a nanotechnology-enhanced environmental mask. In addition to filtration products, the company supplies Superstat(R), a modified hemostatic collagen, to the U.S. military for surgery and extreme wound care.
Safe Harbor Statement
This release may contain statements that are forward looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. EFP does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future results of the company could differ significantly from such forward-looking statements. Sales may be dependent on the success of future marketing campaigns, the signing of definitive agreements with additional distributors and retail vendors, and both the perceived need for EFP's products and the competitive performance of such products in the marketplace.